Implication for health policy/practice/research/medical education:
Findings of this review show that treatment with allopurinol as a purine inhibitor of xanthine oxidase enzyme can decrease oxidative stress and uric acid levels and may help to restore the endothelial function and slow down the progression of renal disorder to end stage renal disease.
Please cite this paper as: Alirezaei A, Argani H, Asgharpour M, Bahadorimonfared A, Bakhtiyari M. An update on allopurinol and kidney failure; new trend for an old drug. J Renal Inj Prev. 2017;6(4):297-302. DOI: 10.15171/jrip.2017.57.